Dental Anaesthetic Market Report 2026

The dental anaesthetic market size has grown steadily in recent years. It will grow from $1.76 billion in 2025 to $1.85 billion in 2026 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to rising number of dental procedures globally, increasing prevalence of oral diseases, growing adoption of local anesthetics in dentistry, expansion of dental clinic infrastructure, improvements in injectable anesthetic formulations.

The dental anaesthetic market size is expected to see strong growth in the next few years. It will grow to $2.26 billion by 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increasing demand for painless dentistry procedures, adoption of computer-controlled anesthetic delivery systems, rising pediatric dental care requirements, growth in outpatient dental surgeries, advancement in long-acting and safer anesthetic drugs. Major trends in the forecast period include ai-assisted precision anesthesia dosage planning and monitoring, smart dental injection systems with automated pain control feedback, minimally invasive needle-free anesthetic delivery innovations, digitally integrated patient pain response tracking systems in dentistry, development of long-acting biodegradable anesthetic formulations for extended procedures.

The increasing prevalence of dental disorders is expected to propel the growth of the dental anaesthetic market going forward. Dental disorders refer to medical conditions affecting the teeth, gums, and other structures of the oral cavity, including dental caries (cavities), periodontal diseases, tooth loss, and oral infections. The rising prevalence of these disorders is primarily driven by increased consumption of sugar-rich and processed foods along with poor oral hygiene practices, both of which are contributing to the development of cavities, gum diseases, and other oral health issues. Dental anaesthetics support the management of dental disorders by enabling pain-free procedures such as cavity fillings, tooth extractions, root canal treatments, and periodontal therapies, thereby encouraging timely patient treatment and allowing dentists to perform complex interventions efficiently. For instance, in December 2024, according to the Parliament of the United Kingdom, a UK-based governing body, in 2022-23, there were approximately 31,165 hospital admissions of children for the extraction of decayed teeth. Therefore, the increasing prevalence of dental disorders is propelling the growth of the dental anaesthetic market.

Leading companies operating in the dental anaesthetic market are focusing on developing innovative formulations such as oral mucosal anesthetics to enhance patient comfort and reduce injection-related anxiety. Oral mucosal anesthetics are topical agents applied directly to the mouth’s mucous membranes to numb the surface tissue, helping reduce pain and discomfort during dental procedures while minimizing the need for injections. For example, in June 2025, VCS Medicals, a US-based medical device company, received U. S. Food and Drug Administration approval for its oral topical anesthetic spray, DentalJect. DentalJect is a spray-based formulation that delivers active anesthetic agents directly to the mucosal tissue, providing rapid onset and precise numbing without the need for injections. Its unique features include ease of application, long-lasting effect, and suitability for patients with needle phobia, making it ideal for routine dental procedures such as fillings, cleanings, and minor oral surgeries.

In August 2023, Pierrel S. p. A., an Italy-based healthcare technology company, acquired 3M’s dental local anesthetic portfolio for $70 million. Through this acquisition, Pierrel S. p. A. aims to expand its global dental anesthetic offerings and strengthen its position in the dental healthcare market, while 3M focuses on streamlining its portfolio and core oral care business. 3M is a US-based technology company specializing in diversified industrial, safety, and healthcare solutions, including oral care products.

Major companies operating in the dental anaesthetic market are Pfizer Inc., Henry Schein Inc., Patterson Companies Inc., Dentsply Sirona Inc., Laboratorios Normon S. A., ZimVie Inc., Septodont Holding SAS, Shofu Inc., Hu-Friedy Mfg. Co. LLC, S. S. White Burs Inc., Laboratorios Inibsa S. A., Pierrel S. p. A., Centrix Inc., Young Innovations Inc., Laboratorios Zeyco S. A. de C. V., Sintetica S. A., Cetylite Industries Inc., Dentalhitec S. A. S., VCS Medical LLC, Sultan Healthcare Inc.

North America was the largest region in the dental anaesthetic market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dental anaesthetic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the dental anaesthetic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dental anaesthetic market consists of sales of long-acting anaesthetics, combination anaesthetic formulations, needle-free injection systems, dental numbing sprays, and specialty gels and ointments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.